Cancer Vaccine Market Research Report: Opportunities and Forecast to 2035
The global cancer vaccine market was valued at USD 14.4 billion in 2025 and is projected to reach USD 17.1 billion in 2026. The market is expected to witness remarkable expansion over the forecast period and is anticipated to reach approximately USD 83.3 billion by 2035, registering a CAGR of 19.2%. The rapid growth of the market is attributed to increasing cancer incidence worldwide, significant advancements in immunotherapy, growing investment in personalized medicine, and rising clinical success of therapeutic vaccine platforms.
